Platelet Storage Lesion: A New Understanding From a Proteomic Perspective

被引:55
作者
Thon, Jonathan N.
Schubert, Peter
Devine, Dana V. [1 ]
机构
[1] UBC Ctr Blood Res, Canadian Blood Serv, Vancouver, BC V6T 1Z3, Canada
基金
加拿大创新基金会; 加拿大健康研究院;
关键词
D O I
10.1016/j.tmrv.2008.05.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelet storage and availability for the purposes of transfusion are currently restricted by a markedly short shelf life of 5 to 7 days owing to an increased risk of bacterial growth and storage-related deterioration called the platelet storage lesion. Because most bacteria grow to confluence within 5 days during storage at room temperature, there is little increased risk of bacterial overgrowth with testing in place, and the only remaining issue is the quality of platelets during the extended storage. Although the manifestations of the storage lesion have been well studied using a variety of in vitro measures, the precise biochemical pathways involved in the initiation and progression of this process have yet to be identified. Proteomics has emerged as a powerful tool to identify and monitor changes during platelet storage and, in combination with biochemical and physiologic studies, facilitates the development of a sophisticated mechanistic view. In this review, we summarize recent experimental work that has led to a detailed overview of protein changes linked to platelet functions and signaling pathways, providing potential targets for inhibitors to ameliorate the storage lesion. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:268 / 290
页数:23
相关论文
共 117 条
[1]  
Abboud M, 1998, LANCET, V351, P959
[2]   Anaphylactoid reaction in a normal donor given granulocyte colony-stimulating factor [J].
Adkins, DR .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :812-813
[3]   Fatal sickle cell crisis after granulocyte colony-stimulating factor administration [J].
Adler, BK ;
Salzman, DE ;
Carabasi, MH ;
Vaughan, WP ;
Reddy, VVB ;
Prchal, JT .
BLOOD, 2001, 97 (10) :3313-3314
[4]   Maculopapular eruption with enlarged macrophages in eight patients receiving G-CSF or GM-CSF [J].
Alvarez-Ruiz, S ;
Peñas, PF ;
Fernández-Herrera, J ;
Sánchez-Pérez, J ;
Fraga, J ;
García-Díez, A .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2004, 18 (03) :310-313
[5]  
Anderlini P, 1997, BLOOD, V90, P903
[6]   Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures [J].
Anderlini, P ;
Przepiorka, D ;
Seong, D ;
Miller, P ;
Sundberg, J ;
Lichtiger, B ;
Norfleet, F ;
Chan, KW ;
Champlin, R ;
Korbling, M .
TRANSFUSION, 1996, 36 (07) :590-595
[7]  
Arici M, 1996, AM J HEMATOL, V52, P123, DOI 10.1002/(SICI)1096-8652(199606)52:2<123::AID-AJH13>3.0.CO
[8]  
2-I
[9]  
Arimura Kosei, 2005, Haematologica, V90, pECR10
[10]  
Azevedo AM, 2001, BONE MARROW TRANSPL, V28, P311